ArticleOrphanet journal of rare diseases2019

Priorities when deciding on participation in early-phase gene therapy trials for Duchenne muscular dystrophy: a best-worst scaling experiment in caregivers and adult patients.

Ryan S Paquin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.